2000
DOI: 10.1002/1098-1101(2000)15:3<169::aid-jca2>3.0.co;2-r
|View full text |Cite
|
Sign up to set email alerts
|

Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: Is its decreased protein S activity clinically related to their development of deep venous thromboses?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
56
1

Year Published

2006
2006
2021
2021

Publication Types

Select...
5
3
2

Relationship

0
10

Authors

Journals

citations
Cited by 74 publications
(58 citation statements)
references
References 10 publications
(9 reference statements)
1
56
1
Order By: Relevance
“…16 It has been reported that solvent/detergent-treated plasma has diminished levels of some antithrombotic proteins. 30,31 Because of concerns regarding this complication, the levels of antithrombotic proteins in PCT-FFP and in the plasma of postoperative patients were measured during this study. The incidence of HAT was comparable between treatment groups, and the levels of antithrombotic proteins in PCT-FFP and C-FFP were similar, as were the levels in patient plasma.…”
Section: Discussionmentioning
confidence: 76%
“…16 It has been reported that solvent/detergent-treated plasma has diminished levels of some antithrombotic proteins. 30,31 Because of concerns regarding this complication, the levels of antithrombotic proteins in PCT-FFP and in the plasma of postoperative patients were measured during this study. The incidence of HAT was comparable between treatment groups, and the levels of antithrombotic proteins in PCT-FFP and C-FFP were similar, as were the levels in patient plasma.…”
Section: Discussionmentioning
confidence: 76%
“…Finally, the citrate concentration in the American product was lower and it had almost no PS activity, whereas European S/D plasma has a moderate reduction of PS activity and antigen [28]. All these differences could have been responsible for the adverse effects reported after the use of S/D plasma produced in the USA, which caused its withdrawal from the market after six deaths for thromboembolic complications in liver-transplanted patients and three cases of deep vein thrombosis in TTP patients plasma-exchanged using S/D plasma [28,29]. On the other hand, in Europe, there have been no reports of thromboembolic episodes directly related to S/D plasma treatment.…”
Section: The Methods Of Inactivationmentioning
confidence: 99%
“…108 Mast and co-workers confirmed that SD-FFP has markedly reduced levels of the antithrombotic proteins antiplasmin and antitrypsin and that these reduced levels are due to conformational changes induced by detergent treatment. 111,112 The SD process utilizes pooled plasma from 100 to 2500 donors and is not amenable to a single-unit viral inactivation process. 111,112 The SD process utilizes pooled plasma from 100 to 2500 donors and is not amenable to a single-unit viral inactivation process.…”
Section: Systems For Inactivation Of Pathogens In Preparation Of Fresmentioning
confidence: 99%